Suppr超能文献

患有神经纤维瘤病-努南综合征儿童的生长激素缺乏症

Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome.

作者信息

Vurallı Doğuş, Gönç Nazlı, Vidaud Dominique, Özön Alev, Alikaşifoğlu Ayfer, Kandemir Nurgün

机构信息

Hacettepe University Faculty of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey, E-mail:

出版信息

J Clin Res Pediatr Endocrinol. 2016 Mar 5;8(1):96-100. doi: 10.4274/jcrpe.2070. Epub 2015 Dec 18.

Abstract

Neurofibromatosis-Noonan syndrome (NFNS) is a distinct entity which shows the features of both NF1 (neurofibromatosis 1) and Noonan syndrome (NS). While growth hormone deficiency (GHD) has been relatively frequently identified in NF1 and NS patients, there is limited experience in NFNS cases. The literature includes only one case report of a NFNS patient having GHD and that report primarily focuses on the dermatological lesions that accompany the syndrome and not on growth hormone (GH) treatment. Here, we present a 13-year-old girl who had clinical features of NFNS with a mutation in the NF1 gene. The case is the first NFNS patient reported in the literature who was diagnosed to have GHD and who received GH treatment until reaching final height. The findings in this patient show that short stature is a feature of NFNS and can be caused by GHD. Patients with NFNS who show poor growth should be evaluated for GHD.

摘要

神经纤维瘤病-努南综合征(NFNS)是一种独特的病症,兼具1型神经纤维瘤病(NF1)和努南综合征(NS)的特征。虽然生长激素缺乏症(GHD)在NF1和NS患者中相对较为常见,但在NFNS病例中的经验有限。文献中仅有一篇关于NFNS患者合并GHD的病例报告,且该报告主要关注该综合征伴随的皮肤病变,而非生长激素(GH)治疗。在此,我们报告一名13岁女孩,她具有NFNS的临床特征且NF1基因存在突变。该病例是文献中首例被诊断为GHD并接受GH治疗直至达到最终身高的NFNS患者。该患者的研究结果表明身材矮小是NFNS的一个特征,且可能由GHD引起。生长发育不良的NFNS患者应评估是否存在GHD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edae/4805056/6a1821769ae8/JCRPE-8-96-g3.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验